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We herein report in vitro functional stability and recording longevity of a fully integrated wireless 
neural interface (INI). The INI uses biocompatible Parylene-C as an encapsulation layer, and was 
immersed in phosphate buffered saline (PBS) for a period of over 150 days. The full functionality 
(wireless radio-frequency power, command, and signal transmission) and the ability of INI to record 
artificial action potentials even after 150 days of PBS soaking without any change in signal/noise 
amplitude constitutes a major milestone in long term stability, and evaluate the encapsulation 
reliability, functional stability, and potential usefulness for future chronic implants. © 2010 
American Institute o f  Physics, [doi; 10.1063/1.3318251 ]
There has been a growing interest to develop biomedical 
implants for use, e.g., in neuroprosthetics that can provide an 
electrical interface to the human nervous system and to allow 
treatment of patients with neurodegenerative diseases, sen­
sory, or movement dysfunctions.1-3 One example of such a 
device is the 100-electrode neural interface based on the 
Utah slant electrode array (USEA), designed to record/ 
stimulate signals from peripheral nerves.4'5 The device is a 
modification of the Utah electrode array, the only penetrating 
multichannel array today available in the Food and Drug 
Administration approved version for use with human pa­
tients. One of the most significant challenges for implanted 
neural interfaces is the percutaneous connector, which is 
likely to cause infections during chronic use. To eliminate 
the wired connections significant research efforts have been 
put into the development of fully integrated wireless neural 
interfaces (INI).6-8 These implantable INI must be designed 
to eventually function in vivo for years. The failure of 
chronic neural implants can occur due to both physiological 
reasons as well as failure of the encapsulation, leading short 
circuits, delamination of films, or corrosion of contacts and 
interconnects, rendering the active and passive electronic 
components in the device nonfunctional or destroying them 
permanently. The challenges have lead to the development/ 
investigation of various encapsulation materials; polyimide, 
parylenes, Si3N4, a-SiC, diamondlike carbon, and histori­
cally known silicones.9-14 The hermiticity verifications are 
based on electrical leakage, impedance, transport rates for 
H20  and ionic species, dissolution rates from IR 
spectra.11'13'14 However, a single material that can satisfy bio­
compatibility and all the aforementioned criteria, and can 
protect the electronic circuitry of INI from the harsh in vivo 
environment is difficult to find. Parylene-C is a biologically 
inert polymer capable of being deposited in conformal nano­
scale layers and is easily patternable to expose the electrode 
tips for sensing, making it a viable material for the implant 
encapsulation. '
‘"Authors to whom correspondence should be addressed. Hlectronic ad­
dresses: asha.sharma@utah.edu and florian.solzbacher@ utah.edu.
The impedance and leakage on the interdigitated electrodes 
(IDEs) in phosphate buffered saline (PBS) have shown that 
encapsulation and insulation properties of Parylene-C are 
stable for more than one year.11 However, in a fully inte­
grated device the variation in the geometry (topography due 
to capacitor, inductive coil, etc.), and several additional pro­
cessing steps (flip chip bonding, interconnects, and tip dein­
sulation) that are not involved in IDEs can alter the diffusion 
rates of PBS and invalidate the failure prediction for a 
chronic implant.
Here, we report the long term in vitro functional stability 
and recording longevity of fully integrated and encapsulated 
USEA/INI-R5 (integrated neural interface-recording version 
5) systems (will be designated as U5 throughout). In vivo
wireless recording of neuronal data using U5 has been re-
17cently demonstrated in an acute experiment. The U5 em­
ployed Parylene-C as an encapsulation layer and was im­
mersed in PBS for a period of over 150 days. The U5, while 
being soaked was powered and configured wirelessly 
through 2.765 MHz inductive link and the transmitted fre­
quency shift keying (FSK) modulated radio-frequency (RF) 
(900 MHz Industrial, scientific, medical-ISM band) signal 
was also recorded wirelessly as a function of soak time. The 
full functionality together with the ability to track artificial 
neural signals for > 150  days of PBS soak provides a mea­
sure of the encapsulation reliability, and the functional sta­
bility in the INI that has not been reported previously in 
wireless implantable devices.
For the fully integrated system, the INI-R5 integrated 
circuit capable of amplifying, digitizing, and transmitting 
neural signals out wirelessly was flip-chip bonded to the 
USEA. The details of the system integration are described 
elsewhere.8'18'19 Silquest A-174 silane (GE silicones) was 
vaporized on the U5 as an adhesion promoter prior to 
Parylene-C coating. Parylene-C film (6 ^m ) was chemically 
vapor deposited using Paratech 3000 labtop deposition sys­
tem (Paratech Coating, Inc.).11 The electrode tips for sensing 
were de-insulated by exposing the tips (30-50  ^m ) with an 
aluminum foil mask followed by a dc pulsed oxygen plasma. 
Custom made transmit coil that uses a class E power ampli-
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FIG. 1. (Color online) (a) Schematic o f  the fully integrated U5 device, (b) 
FSK modulated RF spectra transmitted wirelessly from U5 in  PBS upon 
power up, and command telemetry frequency “0” and telemetry frequency 
“4” .
tier to create a 2.765 MHz waveform of up to 80 V rms from 
a 10 V supply was used to deliver the power. The resulting ac 
magnetic field was inductively coupled to the receiving coil 
present in the U5 and was supplied to the chip in the INI. 
The transmitted RF spectra were measured on spectrum ana­
lyzer (Agilent E4402B). PBS (1% N a d )  in a covered glass 
Petri dish with 11 mm depth was used for long term soak 
testing (PBS depth was maintained at constant level). For 
generating the artificial neural signals. Grass SD-9 pulse 
stimulator was used.
Figure 1(a) shows the schematic of U5 device used for 
the long term stability in PBS. First, the initial bench-top 
testing was performed to check the wireless power/command 
reception and responsiveness to change the telemetry fre­
quency in PBS. Figure 1(b) shows the RF spectra transmitted 
wirelessly from the U5 device in PBS that was measured 
using the monopole antenna connected to the spectrum ana­
lyzer. Upon reception of the wireless inductive power, the RF 
signature appeared with peak at 934.8 MHz and signal 
strength of —89 dBm was measured at 8 cm distance from 
the device. The chip in the INI contains an 8-bit register that 
can take a value between “0” and “255” and sets the com­
mand transmitter frequency in the range of 902-928 MHz 
(ISM band).8 The responsiveness of the INI to the commands 
for two different telemetry frequencies (“0” and “4”) are de­
picted in Fig. 1(b) to show the full functionality of the INI 
in PBS. The strengths of the transmitted RF signal for the 
two telemetry frequencies are close to —87 dBm. The FSK 
modulated RF signal was also analyzed on a custom- 
developed wireless receiver board which displays the fre­
quency and signal strength, and decodes the real time infor­
mation in the MATLAB to a personal computer through the 
universal serial bus interface. Table I shows the wireless FSK 
signal characteristics measured using the receiver board (cor­
responding measurements from spectrum analyzer are also 
shown for comparison). The wireless receiver measured the
TABLE I. FSK modulated wireless RF signal characteristics o f U5 mea­
sured in PBS using a custom-developed wireless receiver and the spectrum 




RF signal using 
wireless receiver 
(MHz, dBm)
RF signal using 
spectrum analyzer 
(MHz, dBm)
t = 0 "0” 911.2, - 5 7 911.9, - 8 7 .4
"4” 912.5, - 5 9 913.5, -8 6 .9
t=  150 davs "0” 910.6, - 5 7 910.8, - 8 0
"4” 912.5, - 5 7 912.6, - 8 1
RF signal for the telemetry frequency “0” at 911.2 MHz with 
strength of —57 dBm at 8 cm from the device. The discrep­
ancies between the signal strengths measured by receiver 
board and the spectrum analyzer can be expected because of 
two different antenna-receiver systems.
In order to study the long term functionality of the INI in 
PBS, the FSK modulated RF signal for telemetry frequency 
“0” that corresponds to 911.2 MHz was monitored as a func­
tion of soak time. Figure 2(a) shows the peak RF signal 
strength and the respective frequency as a function of soak 
time that were extracted from the spectra measured on the 
spectrum analyzer. For clarity, the extracted values are pre­
sented for every after 1 h, although the RF spectra were 
measured every after 20 min. (as depicted in the inset for few 
consecutive intervals). Corresponding measurements using 
the wireless receiver board are shown in Fig. 2(b). It can be 
seen from Figs. 2(a) and 2(b) that the RF functionality of the 
INI is maintained in PBS even after 150 days. The variation 
in the RF strength and the frequency lies within 12% and
0.2% of the initial values, respectively. The RF signal 
strength and the corresponding frequency for PBS soak time 
t = 0 and 150 days for two telemetry frequencies (“0” and 
“4”) are compared in Table I. The INI device continued to 
receive power and commands, and transmitted RF signature 
even after 150 days of soaking in PBS at RT.
In order to test the long term recording ability of the 
electrodes in U5 that was soak tested, in vitro wireless re­
cording was performed in agarose for few channels at time 
t= 0, 108, and 150 days of PBS soaking. The INI was in­
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FIG. 2. (Color online) Transmitted wireless RF signal monitored for the 
telemetry frequency “0” as a function o f soak time in PBS. (a) Peak RF 
signal strengths and the respective frequencies as extracted from the spectra 
measured using the spectrum analyzer (inset shows few consecutive RF 
spectra at 20 min intervals), (b) RF signal strengths and the respective fre­
quencies as monitored on custom-developed wireless receiver board.
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!!IG. 3. (Color online) In vitro wirelessly recorded artificial action potentials 
from one channel at time f= 0  (continuous line), at soak time r= 108 days 
(dotted line), and at soak time r = 150 days (dashed line). Inset shows the 
recording of the artificial action potentials at f= 0 , and at soak time 
r= 150 days at different time scale.
signals were introduced into the agarose. The input signal 
consisted of a biphasic cyclic pulse of 2 V peak-to-peak 
(Ypp) with a frequency of 6 pulses/s (0.4 ms duration). The 
agarose impedance measured between the testing probe and 
the reference Pt electrode separated at 8 cm distance was 
5 k fl at 1 kHz frequency (10 nA current signal). During 
recordings, the probes for injecting the signal into agarose 
were also separated by 8 cm for maintaining the similar im­
pedance and consistence voltage drop (for micrometer 
lengths, the voltage will be dropped to a few millivolt). Fig­
ure 3 shows the real time wirelessly recorded artificial action 
potentials from one channel at t= 0 and after soaking the 
device in PBS for f = 108 and 150 days. The inset compares 
the recording of the artificial action potentials (for soak time 
t= 0 and 150 days) at different time scale. The Vpp of the 
action potential waveform that was wirelessly recorded at 
t= 0, soak time f = 108 days, and soak time f = 150 days is 
684, 646, and 670 fjN , respectively. The variance in the re­
corded Vpp within 5% (with similar noise levels) indicates 
that the long term soaking did not influence the tip deinsu­
lated areas of the electrodes. Similar long term recoding abil­
ity was observed for few other channels (not shown here). 
These in vitro recordings indicate that for a given channel the 
ability to track the artificial action potential is maintained 
even after 150 days of PBS soak.
In conclusion, in vitro functional stability and recording 
longevity of fully integrated and encapsulated wireless neu­
ral interface device was investigated. The device was fully 
functional together with the ability to track artificial action 
potentials even after 150 days soaking without significant 
change in the transmitted RF signal strength and the recorded 
signal/noise amplitude. These in vitro results provide a mea­
sure of the encapsulation reliability, functional stability, and 
the recording longevity in the INI. The stability of the INI in
PBS over five months potentially evaluates the stability in 
real physiological environment, and the usefulness of wire­
less neural interface for future chronic implants.
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